common glp-1 drugs List of approved and pending medications GLP-1 Medications | Daniel Stark
Description
Ann Intern Med 173(4):278286
References: Kaplan LM, Golden A, Jinnett K, et al
22,53 In the LEADER trial, which enrolled 9,340 patients with T2D at high cardiovascular risk, liraglutide demonstrated modest reduction in systolic BP (mean difference: 1.2 mm Hg
Grasset E, Puel A, Charpentier J, et al
Summary of included studies regarding the adverse psychiatric outcomes associated with GLP-1-RAs)
Before reaching that conclusion, there are several factors to evaluate
